REPORT/RECOMMENDATION TO THE BOARD OF SUPERVISORS
OF SAN BERNARDINO COUNTY
AND RECORD OF ACTION
June 13, 2023
FROM
WILLIAM L. GILBERT, Director, Arrowhead Regional Medical Center
SUBJECT
Title
Amendment to Agreement with Cepheid for the Purchase of Cepheid Reagent Tests
End
RECOMMENDATION(S)
Recommendation
Approve Amendment No. 1 to Agreement No. 23-26 with Cepheid to expand the types of reagents available for purchase, with no change to the not-to-exceed amount of $952,300 or the term of January 1, 2023 through December 31, 2025.
(Presenter: William L. Gilbert, Director, 580-6150)
Body
COUNTY AND CHIEF EXECUTIVE OFFICER GOALS & OBJECTIVES
Provide for the Safety, Health and Social Service Needs of County Residents.
FINANCIAL IMPACT
Approval of this item will not result in the use of Discretionary General funding (Net County Cost). The amendment has no additional financial impact as it is only expanding the types of reagents that may be purchased utilizing this agreement. The cost of $952,300 is funded by State Medi-Cal, Federal Medicare, private insurances, and other departmental revenue. Funding sources may change in the future pending any legislative activity related to the repeal and/or replacement of the Affordable Care Act. Adequate appropriation and revenue have been included in the Arrowhead Regional Medical Center (ARMC) 2022-23 budget and will be included in future recommended budgets.
BACKGROUND INFORMATION
The recommended Amendment No. 1 to Agreement No. 23-26 with Cepheid will allow ARMC to purchase Cepheid Clostridium Difficile and Epidemic 027 strain (C. diff/Epi) reagents directly from Cepheid. These reagents are used to diagnose Clostridium difficile (C. diff) infection, which has been identified as a cause of hospital outbreaks worldwide. Accurate and rapid diagnosis is essential to improve patient outcome and prevent disease spread.
ARMC was previously purchasing these reagents from Cepheid through Vizient Contr...
Click here for full text